Arcapta Neohaler (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Arcapta Neohaler drug offered from Novartis Pharmaceuticals Corporation. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | Indacaterol maleate |
| SUBSTANCE NAME: | INDACATEROL MALEATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| ROUTE: | ORAL; RESPIRATORY (INHALATION) |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-07-01 |
| END MARKETING DATE: | 0000-00-00 |
Arcapta Neohaler HUMAN PRESCRIPTION DRUG Details:
| Item Description | Arcapta Neohaler from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 75(ug/1) |
| START MARKETING DATE: | 2011-07-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0619_dd22d6db-adf4-4e36-b243-c23f3d4ba08e |
| PRODUCT NDC: | 0078-0619 |
| APPLICATION NUMBER: | NDA022383 |
Other INDACATEROL MALEATE Pharmaceutical Manufacturers / Labelers:
